Literature DB >> 36237638

Expression and significance of CDX2, FXR, and TGR5 in esophageal cancer.

Hongying Zhang1,2, Xiaodong Qu1, Na Wang1, Lifeng Zhang1, Ting Yuan1,3, Miao Shi1,4, Nina Sun1,4, Donghong Yuan5, Hanbing Ning6, Mengyun Zhao7, Yongxi Wang8, Zhen Ni1,9, Chuan Han1,10, Yongquan Shi1.   

Abstract

This study explored the expression and significance of three critical morphogenesis genes in normal esophagus, reflux esophagitis (RE), Barrett's esophagus (BE), esophageal adenocarcinoma (EA), and esophageal squamous cell carcinoma (ESCC). Esophageal tissue samples and tissue microarrays were used. CDX2, FXR, and TGR5 protein expression were measured by immunohistochemistry in normal esophageal, RE, BE, EA, and ESCC tissues. All 3 proteins had markedly changed expression during the progression of EA. The expressions of CDX2 and FXR were positively correlated in EA. In addition, TGR5 expression was positively correlated with CDX2 in RE and BE. The expressions of CDX2 and FXR were also positively correlated in ESCC. Although CDX2, FXR, and TGR5 were upregulated in ESCC, these factors might not be markers for the prognosis of ESCC. These results suggested that CDX2, FXR, and TGR5 might play different roles in EA and ESCC. They may represent novel therapeutic targets for patients with these cancers. IJCEP
Copyright © 2022.

Entities:  

Keywords:  BE; CDX2; Esophageal squamous cell carcinoma; FXR; TGR5

Year:  2022        PMID: 36237638      PMCID: PMC9547995     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  30 in total

1.  Differential expression of the nuclear receptors farnesoid X receptor (FXR) and pregnane X receptor (PXR) for grading dysplasia in patients with Barrett's oesophagus.

Authors:  Anouk van de Winkel; Katinka P M van Zoest; Herman van Dekken; Leon M G Moons; Ernst J Kuipers; Luc J W van der Laan
Journal:  Histopathology       Date:  2011-01       Impact factor: 5.087

2.  Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice.

Authors:  Debra G Silberg; Jessica Sullivan; Eugene Kang; Gary P Swain; Jennifer Moffett; Newman J Sund; Sara D Sackett; Klaus H Kaestner
Journal:  Gastroenterology       Date:  2002-03       Impact factor: 22.682

Review 3.  Bile acid metabolism and FXR-mediated effects in human cholestatic liver disorders.

Authors:  Antonio Molinaro; Hanns-Ulrich Marschall
Journal:  Biochem Soc Trans       Date:  2022-02-28       Impact factor: 5.407

4.  Endoscopic Screening Program for Control of Esophageal Adenocarcinoma in Varied Populations: A Comparative Cost-Effectiveness Analysis.

Authors:  Joel H Rubenstein; Amir-Houshang Omidvari; Brianna N Lauren; William D Hazelton; Francesca Lim; Sarah Xinhui Tan; Chung Yin Kong; Minyi Lee; Ayman Ali; Chin Hur; John M Inadomi; Georg Luebeck; Iris Lansdorp-Vogelaar
Journal:  Gastroenterology       Date:  2022-03-29       Impact factor: 33.883

5.  How does intestinal-type intraductal papillary mucinous neoplasm emerge? CDX2 plays a critical role in the process of intestinal differentiation and progression.

Authors:  Yuko Omori; Yusuke Ono; Toshikazu Kobayashi; Fuyuhiko Motoi; Hidenori Karasaki; Yusuke Mizukami; Naohiko Makino; Yoshiyuki Ueno; Michiaki Unno; Toru Furukawa
Journal:  Virchows Arch       Date:  2020-04-15       Impact factor: 4.064

6.  Role of a novel bile acid receptor TGR5 in the development of oesophageal adenocarcinoma.

Authors:  Jie Hong; Jose Behar; Jack Wands; Murray Resnick; Li Juan Wang; Ronald A DeLellis; David Lambeth; Rhonda F Souza; Stuart J Spechler; Weibiao Cao
Journal:  Gut       Date:  2009-11-18       Impact factor: 23.059

7.  Conversion of gastric mucosa to intestinal metaplasia in Cdx2-expressing transgenic mice.

Authors:  Hiroyuki Mutoh; Yoji Hakamata; Kiichi Sato; Akashi Eda; Ichiro Yanaka; Sayaka Honda; Hiroyuki Osawa; Yoshinari Kaneko; Kentaro Sugano
Journal:  Biochem Biophys Res Commun       Date:  2002-06-07       Impact factor: 3.575

8.  TGR5 expression in benign, preneoplastic and neoplastic lesions of Barrett's esophagus: Case series and findings.

Authors:  Shivali Marketkar; Dan Li; Dongfang Yang; Weibiao Cao
Journal:  World J Gastroenterol       Date:  2017-02-28       Impact factor: 5.742

9.  Activation of EGFR-DNA-PKcs pathway by IGFBP2 protects esophageal adenocarcinoma cells from acidic bile salts-induced DNA damage.

Authors:  Zhangjian Zhou; Heng Lu; Shoumin Zhu; Ahmed Gomaa; Zheng Chen; Jin Yan; Kay Washington; Wael El-Rifai; Chengxue Dang; Dunfa Peng
Journal:  J Exp Clin Cancer Res       Date:  2019-01-09

Review 10.  The Immune Underpinnings of Barrett's-Associated Adenocarcinogenesis: a Retrial of Nefarious Immunologic Co-Conspirators.

Authors:  Louisa Tambunting; Dermot Kelleher; Shane Patrick Duggan
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2022-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.